MDC-2021

N/A

Report date: 2023/01/07 12:17:29

Base Information

Drug NameMDC-2021
Drug Alias NameMDC-2021
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor modulatorsApoptosis stimulants
TargetsCannabinoid receptor
Therapy Area/IndicationsLymphoma, T-Cell, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedC Biopharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMedC Biopharma Corp
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell, Cutaneous
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A